Globe Life (NYSE:GL) CEO Frank Svoboda Sells 12,500 Shares of Stock

Globe Life Inc. (NYSE:GL) CEO Frank Svoboda sold 12,500 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the transaction, the chief executive officer owned 35,868 shares of the company’s stock, valued at approximately $5,192,969.04. The trade was a 25.84% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Globe Life Trading Down 1.5%

GL opened at $143.79 on Thursday. Globe Life Inc. has a twelve month low of $109.38 and a twelve month high of $152.71. The company has a fifty day moving average of $141.23 and a 200-day moving average of $138.52. The stock has a market cap of $11.45 billion, a PE ratio of 10.21 and a beta of 0.47. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The firm had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.53 billion. During the same period last year, the company posted $3.14 EPS. The business’s revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, sell-side analysts predict that Globe Life Inc. will post 13.87 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have issued reports on GL. Truist Financial boosted their price target on Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a research note on Friday, February 6th. Morgan Stanley reiterated an “overweight” rating and set a $176.00 target price on shares of Globe Life in a research report on Monday, December 15th. JPMorgan Chase & Co. increased their target price on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, February 13th. Finally, Piper Sandler reiterated an “overweight” rating and set a $167.00 price objective on shares of Globe Life in a report on Friday, November 21st. Eight analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $171.22.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. Vanguard Group Inc. grew its stake in Globe Life by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock valued at $1,411,311,000 after purchasing an additional 86,349 shares during the period. Invesco Ltd. raised its stake in shares of Globe Life by 3.9% during the 2nd quarter. Invesco Ltd. now owns 3,921,439 shares of the company’s stock worth $487,396,000 after purchasing an additional 147,644 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Globe Life by 2.9% in the 2nd quarter. Geode Capital Management LLC now owns 2,722,768 shares of the company’s stock worth $339,875,000 after buying an additional 76,995 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Globe Life by 2.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,135,861 shares of the company’s stock valued at $298,732,000 after buying an additional 59,629 shares during the period. Finally, Morgan Stanley increased its holdings in Globe Life by 7.2% during the fourth quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock worth $260,176,000 after buying an additional 125,567 shares during the last quarter. 81.61% of the stock is owned by institutional investors.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.